- Home
- PRME vs EMD Comparison
PRME vs EMD Comparison
Compare PRME & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRME | EMD |
|---|---|---|
| Founded | 2019 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 613.9M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRME | EMD |
|---|---|---|
| Price | $4.24 | $10.83 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.42 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 248.5K |
| Earning Date | 02-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,977,000.00 | N/A |
| Revenue This Year | $111.80 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 647.13 | N/A |
| 52 Week Low | $1.11 | $7.85 |
| 52 Week High | $6.94 | $9.55 |
Technical Indicators
Market Signals| Indicator | PRME | EMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.22 | 53.28 |
| Support Level | $4.08 | $10.75 |
| Resistance Level | $4.73 | $11.00 |
| Average True Range (ATR) | 0.35 | 0.11 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 50.00 | 50.00 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.